Company / Working Capital per Share
NewAmsterdam Pharma Co N.V. Working Capital per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$4.98
FY2025
5-year range
$3.61 / $23.30
FY2022-FY2025
Trend
-37.9%
vs FY2024
Sector context
#105 of 208
Health Care
What the data says
At $4.98, NewAmsterdam Pharma Co N.V.'s working capital per share ranks #105 of 208 in the Health Care sector. Improved from $3.61 to $4.98 over the past 2 years.
Based on SEC 10-K filings.
4.98 in FY2025 with a 3-year CAGR of -40.2%.
Improved from $3.61 to $4.98 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -40.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#105 of 208 in Health CareTop 50% of 208This company $4.98 Sector average $160.16
▼
-96.9% below sector average
Key checks
Key Insights
- In FY2025, working capital per share decreased 37.9% year-over-year.
- Ranks #105 out of 208 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.01 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.98 | -37.9% |
| FY2024 | $8.02 | +121.9% |
| FY2023 | $3.61 | -84.5% |
| FY2022 | $23.30 | - |
| FY2021 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026